Yansheng Liu

Yansheng Liu

Yale University

H-index: 34

North America-United States

About Yansheng Liu

Yansheng Liu, With an exceptional h-index of 34 and a recent h-index of 28 (since 2020), a distinguished researcher at Yale University, specializes in the field of Proteomics, Systems Biology, Cancer Proteomics.

His recent articles reflect a diverse array of research interests and contributions to the field:

Wnt5 controls splenic myelopoiesis and neutrophil functional ambivalency during DSS-induced colitis

The CUL5 E3 ligase complex negatively regulates central signaling pathways in CD8+ T cells

The SysteMHC Atlas v2. 0, an updated resource for mass spectrometry-based immunopeptidomics

Proteogenomic characterization of small cell lung cancer identifies biological insights and subtype-specific therapeutic strategies

EGFR targeting PhosTACs as a dual inhibitory approach reveals differential downstream signaling

A fully automated FAIMS-DIA mass spectrometry-based proteomic pipeline

Reciprocal inhibition of PIN1 and APC/CCDH1 controls timely G1/S transition and creates therapeutic vulnerability

Network-based elucidation of colon cancer drug resistance by phosphoproteomic time-series analysis

Yansheng Liu Information

University

Position

School of Medicine

Citations(all)

8261

Citations(since 2020)

6611

Cited By

4219

hIndex(all)

34

hIndex(since 2020)

28

i10Index(all)

58

i10Index(since 2020)

55

Email

University Profile Page

Google Scholar

Yansheng Liu Skills & Research Interests

Proteomics

Systems Biology

Cancer Proteomics

Top articles of Yansheng Liu

Title

Journal

Author(s)

Publication Date

Wnt5 controls splenic myelopoiesis and neutrophil functional ambivalency during DSS-induced colitis

Cell Reports

Yi Luan

Jiajia Hu

Qijun Wang

Xujun Wang

Wenxue Li

...

2024/3/26

The CUL5 E3 ligase complex negatively regulates central signaling pathways in CD8+ T cells

Nature Communications

Xiaofeng Liao

Wenxue Li

Hongyue Zhou

Barani Kumar Rajendran

Ao Li

...

2024/1/19

The SysteMHC Atlas v2. 0, an updated resource for mass spectrometry-based immunopeptidomics

Nucleic Acids Research

Xiaoxiang Huang

Ziao Gan

Haowei Cui

Tian Lan

Yansheng Liu

...

2024/1/5

Proteogenomic characterization of small cell lung cancer identifies biological insights and subtype-specific therapeutic strategies

Cell

Qian Liu

Jing Zhang

Chenchen Guo

Mengcheng Wang

Chenfei Wang

...

2024/1/4

EGFR targeting PhosTACs as a dual inhibitory approach reveals differential downstream signaling

Science Advances

Zhenyi Hu

Po-Han Chen

Wenxue Li

Mackenzie Krone

Sijin Zheng

...

2024/3/27

A fully automated FAIMS-DIA mass spectrometry-based proteomic pipeline

Cell Reports Methods

Luke Reilly

Erika Lara

Daniel Ramos

Ziyi Li

Caroline B Pantazis

...

2023/10/23

Reciprocal inhibition of PIN1 and APC/CCDH1 controls timely G1/S transition and creates therapeutic vulnerability

Research Square

Shizhong Ke

Fabin Dang

Lin Wang

Jia-Yun Chen

Mandar T Naik

...

2023/1/19

Network-based elucidation of colon cancer drug resistance by phosphoproteomic time-series analysis

bioRxiv

George Rosenberger

Wenxue Li

Mikko Turunen

Jing He

Prem S Subramaniam

...

2023/2/16

Oncogene-like addiction to aneuploidy in human cancers

Science

Vishruth Girish

Asad A Lakhani

Sarah L Thompson

Christine M Scaduto

Leanne M Brown

...

2023/7/6

Targeted dephosphorylation of tau by phosphorylation targeting chimeras (PhosTACs) as a therapeutic modality

Journal of the American Chemical Society

Zhenyi Hu

Po-Han Chen

Wenxue Li

Todd Douglas

John Hines

...

2023/2/8

An optogenetic-phosphoproteomic study reveals dynamic Akt1 signaling profiles in endothelial cells

Nature Communications

Wenping Zhou

Wenxue Li

Shisheng Wang

Barbora Salovska

Zhenyi Hu

...

2023/6/26

Post‐translational modification and phenotype

Barbora Salovska

Yansheng Liu

2023/2

Meeting Report on the 2nd Chinese American Society for Mass Spectrometry Conference: Advancing Biological and Pharmaceutical Mass Spectrometry

Molecular & Cellular Proteomics

Yue Chen

Ying Ge

Xianlin Han

Ling Hao

Tao Huan

...

2023/6/1

Phosphoproteomic analysis of metformin signaling in colorectal cancer cells elucidates mechanism of action and potential therapeutic opportunities

Clinical and Translational Medicine

Barbora Salovska

Erli Gao

Sophia Müller‐Dott

Wenxue Li

Carlos Chacon Cordon

...

2023/2

7SK methylation by METTL3 promotes transcriptional activity

Science advances

Marcelo Perez-Pepe

Anthony W Desotell

Hengyi Li

Wenxue Li

Bing Han

...

2023/5/10

Calponin 2 regulates ketogenesis to mitigate acute kidney injury

JCI insight

Yuan Gui

Zachary Palanza

Priya Gupta

Hanwen Li

Yuchen Pan

...

2023/11/11

Toward a hypothesis‐free understanding of how phosphorylation dynamically impacts protein turnover

Proteomics

Wenxue Li

Barbora Salovska

Eugenio F Fornasiero

Yansheng Liu

2023/2

A basic phosphoproteomic-DIA workflow integrating precise quantification of phosphosites in systems biology

Biophysics Reports

Yi Di

Wenxue Li

Barbora Salovska

Qian Ba

Zhenyi Hu

...

2023/4/4

Proteotype Co-evolution and Diversity in Mammals

bioRxiv

Qian Ba

Yuanyuan Hei

Anasuya Dighe

Wenxue Li

Jamie Maziarz

...

2022/6/10

WDR5 promotes breast cancer growth and metastasis via KMT2-independent translation regulation

bioRxiv

Wesley L Cai

Jocelyn F Chen

Huacui Chen

Emily Wingrove

Sarah J Kurley

...

2022/3/30

See List of Professors in Yansheng Liu University(Yale University)

Co-Authors

academic-engine